Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

Share Price is delayed by 15 minutes
Get Live Data
49.35    -2.35 (-4.55%)
Bid:
48.45
Ask:
49.00
Spread: 0.55 (1.135%)
Market Cap: £647.76m
IQE Live PriceLast checked at - London Stock Exchange

Intraday IQE Share Chart

Form 8.5 (EPT/RI) - IQE plc

11 Sep 2025 09:56

RNS Number : 9701Y
Numis Securities Limited
11 September 2025
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Numis Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

IQE plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Deutsche Numis is acting as Joint Corporate Broker to IQE plc

(d) Date dealing undertaken:

10/09/2025

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ Sales

 

Total number of securities

Highest price per unit paid/received (GBP)

Lowest price per unit paid/received (GBP)

1p ordinary

Purchases

 60,379

 0.0760

 0.0758

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

11/09/2025

Contact name:

Selim Miah

Telephone number:

+44 121 407 9441

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERKZGMLRMKGKZG
Date   Source Headline
8th Sep 20253:00 pmRNSIQE plc: Holding(s) in Company
8th Sep 20257:00 amRNSIQE plc: Trading Update & Strategic Review Update
5th Sep 20254:00 pmRNSIQE plc: Holding(s) in Company
1st Sep 20254:00 pmRNSIQE plc: Director/PDMR Shareholding
1st Sep 202510:00 amRNSIQE plc: Total Voting Rights
4th Aug 202511:00 amRNSIQE plc: Total Voting Rights - Amended
1st Aug 20258:00 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSIQE plc: Director/PDMR Shareholding
30th Jun 20254:00 pmRNSIQE plc: Total Voting Rights and Block Admission
30th Jun 20251:00 pmRNSIQE plc: Result of AGM
30th Jun 20257:00 amRNSIQE plc: AGM Notice
16th Jun 20257:00 amRNS-RIQE plc: Completion of joint ULTRARAM™ project
9th Jun 202512:00 pmRNSIQE plc: Holding(s) in Company
9th Jun 20257:00 amRNSIQE plc: Director/PDMR Shareholding
2nd Jun 20254:00 pmRNSIQE plc: Total Voting Rights
27th May 20257:00 amRNSIQE plc: Notice of AGM and Annual Report
13th May 20257:00 amRNSIQE plc: FY 2024 Financial Results
1st May 20257:00 amRNSIQE plc: Notice of Full Year Results
30th Apr 20254:00 pmRNSIQE plc: Total Voting Rights
10th Apr 20257:00 amRNSIQE plc: IQE and X-FAB sign JDA for GaN Power
4th Apr 202512:00 pmRNSIQE plc: Holding(s) in Company
3rd Apr 20257:00 amRNSIQE plc: Holding(s) in Company
1st Apr 20254:00 pmRNSIQE plc: Total Voting Rights
24th Mar 20257:00 amRNSIQE plc: IQE secures Infrared customer commitments
17th Mar 20251:00 pmRNSIQE plc: Holding(s) in Company
14th Mar 202512:00 pmRNSIQE plc: Director/PDMR Shareholding
14th Mar 20257:00 amRNSIQE plc: Closing of CLN Financing
10th Mar 20254:00 pmRNSIQE plc: Results of General Meeting
28th Feb 20254:00 pmRNSIQE plc: Total Voting Rights
12th Feb 20257:00 amRNSIQE plc: Convertible Loan Note Financing
4th Feb 20257:00 amRNSIQE plc: Total Voting Rights
24th Jan 20257:00 amRNSIQE and Quintessent partner on Quantum Dot for AI
23rd Jan 20257:00 amRNSIQE plc: Pre-close Trading Update
2nd Jan 20254:00 pmRNSIQE plc: Total Voting Rights and Block Admission
20th Dec 20247:00 amRNSIQE plc: Board Change
18th Dec 202410:15 amRNSIQE plc: Holding(s) in Company
12th Dec 20247:00 amRNSIQE plc: Holding(s) in Company
4th Dec 20247:00 amRNSIQE plc: Completion of Pennsylvania site sale
2nd Dec 20244:00 pmRNSIQE plc: Total Voting Rights
29th Nov 202411:24 amRNSLong Term Incentive Plan (LTIP) Award
25th Nov 202410:59 amRNSIQE plc: Holding(s) in Company
18th Nov 20247:00 amRNSIQE plc: Trading Update
15th Nov 20247:00 amRNSHolding(s) in Company
14th Nov 20247:00 amRNSIQE plc: Holding(s) in Company
31st Oct 20247:00 amRNSIQE plc: Total Voting Rights
29th Oct 20247:00 amRNSIQE plc: IQE announces departure of CEO
14th Oct 20244:00 pmRNSIQE plc: Holding(s) in Company
8th Oct 20247:00 amRNSIQE plc: Appointment of NED and Chair-elect
30th Sep 20244:00 pmRNSIQE plc: Total Voting Rights
17th Sep 20243:00 pmRNSIQE plc: Holding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.